Skip to Main Content

Advertisement

Issue Archive

Table of Contents

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY

In this issue of Blood, Marlein et al1  identify a tumor-specific NOX2-dependent transfer of mitochondria from bone marrow stromal cells (BMSCs) to acute myeloid leukemia (AML) cells via AML-derived tunneling nanotubes (see figure), supporting inhibition of NOX2 as a novel therapeutic strategy in AML.

INSIDE BLOOD COMMENTARY

In this issue of Blood, Kamikubo et al broaden the already diverse tissue factor (TF) repertoire to include activation of anti–hemophilia A clotting factor VIII (FVIII), which amplifies coagulation initiation.1 

REVIEW ARTICLE

CLINICAL TRIALS AND OBSERVATIONS

IMMUNOBIOLOGY AND IMMUNOTHERAPY

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

THROMBOSIS AND HEMOSTASIS

Publisher's Note: There is an Inside Blood Commentary on this article in this issue.

LETTERS TO BLOOD

BLOOD WORK

ERRATA

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement

X